Published in J Clin Oncol on September 15, 2001
Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2. Proc Natl Acad Sci U S A (2003) 1.32
Liver regeneration is an angiogenesis- associated phenomenon. Ann Surg (2002) 1.21
Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma. Neuro Oncol (2005) 1.16
Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches. Ann Surg (2003) 1.11
Antiangiogenic therapy and mechanisms of tumor resistance in malignant glioma. J Oncol (2010) 1.05
New chemotherapy strategies and biological agents in the treatment of childhood ependymoma. Childs Nerv Syst (2009) 0.88
Pivotal role of vascular endothelial growth factor pathway in tumor angiogenesis. Ann Surg Treat Res (2015) 0.85
Attenuation of insulin-resistance-based hepatocarcinogenesis and angiogenesis by combined treatment with branched-chain amino acids and angiotensin-converting enzyme inhibitor in obese diabetic rats. J Gastroenterol (2009) 0.83
Clinical implications of angiogenesis in cancers. Vasc Health Risk Manag (2006) 0.83
Cellular actions and signaling by endostatin. Crit Rev Eukaryot Gene Expr (2002) 0.82
Angiostatin inhibits experimental liver fibrosis in mice. Int J Colorectal Dis (2004) 0.80
Current status and perspective of angiogenesis and antivascular therapeutic strategy: non-small cell lung cancer. Int J Clin Oncol (2006) 0.78
Combined treatment of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates hepatic dysplastic nodule in a patient with liver cirrhosis. World J Gastroenterol (2007) 0.76
Antiangiogenesis cocktails - stirred or shaken? MedGenMed (2004) 0.76
Combined vindesine and razoxane shows antimetastatic activity in advanced soft tissue sarcomas. Clin Exp Metastasis (2007) 0.75
Chemotherapy for small cell lung cancer: a comprehensive review. Oncol Rev (2012) 0.75
Characterization and in vivo evaluation of novel lipid-chlorambucil nanospheres prepared using a mixture of emulsifiers for parenteral administration. Int J Nanomedicine (2010) 0.75
Hepatic tumor growth: target for angiogenesis inhibition? World J Surg (2005) 0.75